Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sugiyama, Kazuo ^a   Ebinuma, Hirotoshi ^a   Nakamoto, Nobuhiro ^a   Sakasegawa, Noriko ^a   Murakami, Yuko ^b   Chu, Po Sung ^a   Usui, Shingo ^a   Ishibashi, Yuka ^a   Wakayama, Yuko ^a   Taniki, Nobuhito ^a   Murata, Hiroko ^a   Saito, Yoshimasa ^b   Fukasawa, Masayoshi ^c   Saito, Kyoko ^c   Yamagishi, Yoshiyuki ^a   Wakita, Takaji ^c   Takaku, Hiroshi ^d   Hibi, Toshifumi ^e   Saito, Hidetsugu ^a,b   Kanai, Takanori ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^e KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHOLESTEROL; DESMOSTEROL; FATTY ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PENTOSE PHOSPHATE; PHOSPHOLIPID; PURINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; CULTURE MEDIUM; FAT DROPLET; NFE2L2 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NUCLEOTIDE; VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL HYPERMETABOLISM; CELL LINE; CELL METABOLISM; CELL NUCLEUS; CITRIC ACID CYCLE; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOSOL; FATTY LIVER; GLYCOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HPI CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; METABOLOMICS; NONHUMAN; PURINE SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL CLONE; CULTURE MEDIUM; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HEPACIVIRUS; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSCRIPTION INITIATION; VIROLOGY;

AMINO ACIDS; BIOSYNTHETIC PATHWAYS; CELL LINE; CHOLESTEROL; CLONE CELLS; CULTURE MEDIA; DESMOSTEROL; FATTY ACIDS; FATTY LIVER; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTRACELLULAR SPACE; LIPID DROPLETS; METABOLOMICS; NADP; NF-E2-RELATED FACTOR 2; NUCLEOTIDES; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRIGLYCERIDES; VIRAL PROTEINS;

EID: 84899517625     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094460     Document Type: Article

References (56)

1. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, et al. (1993) Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18: 1326-1333. (Pubitemid 23348417)
2. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K (1991) Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences of the United States of America 88: 5547-5551. (Pubitemid 21914782)
3. Hijikata M, Mizushima H, Tanji Y, Komoda Y, Hirowatari Y, et al. (1993) Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90: 10773-10777. (Pubitemid 23347125)
4. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796. (Pubitemid 41021213)
5. Sugiyama K, Suzuki K, Nakazawa T, Funami K, Hishiki T, et al. (2009) Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro. J Virol 83: 6922-6928.
6. Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, et al. (2013) Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J Virol 87: 8169-8178.
7. Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, et al. (2010) Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 107: 3141-3145.
8. Silberstein E, Mihalik K, Ulitzky L, Plant EP, Puig M, et al. (2010) Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture. PLoS Pathog 6: e1000910.
9. Bauhofer O, Ruggieri A, Schmid B, Schirmacher P, Bartenschlager R (2012) Persistence of HCV in Quiescent Hepatic Cells Under Conditions of an Interferon-Induced Antiviral Response. Gastroenterology 143: 429-438.e428.
10. Goodman ZD, Ishak KG (1995) Histopathology of hepatitis C virus infection. Semin Liver Dis 15: 70-81.
11. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, et al. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79.
12. Moi P, Chan K, Asunis I, Cao A, Kan YW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91: 9926-9930. (Pubitemid 24311921)
13. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322. (Pubitemid 27373291)
14. Uruno A, Motohashi H (2011) The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide 25: 153-160.
15. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, et al. (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 1089-1097. (Pubitemid 47338147)
16. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM (2003) Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 77: 4160-4168. (Pubitemid 36350955)
17. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM (2004) Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324: 450-461. (Pubitemid 38797861)
18. Yamazaki T, Sasaki E, Kakinuma C, Yano T, Miura S, et al. (2005) Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J Biol Chem 280: 21506-21514. (Pubitemid 40805716)
19. Partin JS, Partin JC, Schubert WK, McAdams AJ (1974) Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. Gastroenterology 67: 107-118.
20. Date T, Morikawa K, Tanaka Y, Tanaka-Kaneko K, Sata T, et al. (2012) Replication and infectivity of a novel genotype 1b hepatitis C virus clone. Microbiol Immunol 56: 308-317.
21. Kapadia SB, Chisari FV (2005) Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A 102: 2561-2566. (Pubitemid 40279416)
22. Hirata Y, Ikeda K, Sudoh M, Tokunaga Y, Suzuki A, et al. (2012) Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLoS Pathog 8: e1002860.
23. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, et al. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067. (Pubitemid 28417341)
24. Barba G, Harper F, Harada T, Kohara M, Goulinet S, et al. (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94: 1200-1205. (Pubitemid 27087828)
25. Huang H, Sun F, Owen DM, Li W, Chen Y, et al. (2007) Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 104: 5848-5853. (Pubitemid 47175622)
26. Gastaminza P, Cheng G, Wieland S, Zhong J, Liao W, et al. (2008) Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82: 2120-2129. (Pubitemid 351293514)
27. Icard V, Diaz O, Scholtes C, Perrin-Cocon L, Ramiere C, et al. (2009) Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS ONE 4: e4233.
28. Ikeda M, Abe K, Yamada M, Dansako H, Naka K, et al. (2006) Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44: 117-125. (Pubitemid 44049145)
29. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 3: 87-98.
30. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA. Science 309: 1577-1581. (Pubitemid 41266486)
31. Hsu SH, Wang B, Kota J, Yu J, Costinean S, et al. (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122: 2871-2883.
32. Zerenturk EJ, Sharpe LJ, Ikonen E, Brown AJ (2013) Desmosterol and DHCR24: Unexpected new directions for a terminal step in cholesterol synthesis. Progress in Lipid Research 52: 666-680.
33. Rodgers MA, Villareal VA, Schaefer EA, Peng LF, Corey KE, et al. (2012) Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc 134: 6896-6899.
34. Miyoshi H, Moriya K, Tsutsumi T, Shinzawa S, Fujie H, et al. (2011) Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J Hepatol 54: 432-438.
35. Seronello S, Ito C, Wakita T, Choi J (2010) Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem 285: 845-854.
36. Lee JL, Mukhtar H, Bickers DR, Kopelovich L, Athar M (2003) Cyclooxygen-ases in the skin: pharmacological and toxicological implications. Toxicol Appl Pharmacol 192: 294-306. (Pubitemid 37311345)
37. Ziboh VA, Miller CC, Cho Y (2000) Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr 71: 361S-366S. (Pubitemid 30046143)
38. Glass CK, Olefsky JM (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 15: 635-645.
39. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
40. Mitsuishi Y Fau - Motohashi H, Motohashi H Fau - Yamamoto M, Yamamoto M (2012) The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism.
41. Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, et al. (2013) Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493: 542-546.
42. Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, et al. (2011) Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85: 8556-8568.
43. Masson J, Sagne C, Hamon M, El Mestikawy S (1999) Neurotransmitter transporters in the central nervous system. Pharmacol Rev 51: 439-464. (Pubitemid 29420211)
44. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, et al. (2004) The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch 447: 465-468. (Pubitemid 38241432)
45. Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121: 29-40.
46. Fuchs BC, Bode BP (2005) Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15: 254-266. (Pubitemid 41065034)
47. Lo M, Wang YZ, Gout PW (2008) The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215: 593-602. (Pubitemid 351632680)
48. Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, et al. (2011) Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 Cells. PLoS ONE 6: e24957.
49. Carvajal-Yepes M, Himmelsbach K, Schaedler S, Ploen D, Krause J, et al. (2011) Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. J Biol Chem 286: 8941-8951.
50. Ogawa K, Hishiki T, Shimizu Y, Funami K, Sugiyama K, et al. (2009) Hepatitis C virus utilizes lipid droplet for production of infectious virus. Proc Jpn Acad Ser B Phys Biol Sci 85: 217-228.
51. Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, et al. (2013) A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis 57: 230-236.
52. Putte DEFvd, Makris M, Fischer K, Yee TT, Kirk L, et al. (2013) Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders. Journal of Hepatology.
53. Jaramillo MC, Zhang DD (2013) The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27: 2179-2191.
54. Gañán-Gómez I, Wei Y, Yang H, Boyano-Adánez MC, García-Manero G (2013) Oncogenic functions of the transcription factor Nrf2. Free Radical Biology and Medicine.
55. Kato N, Sugiyama K, Namba K, Dansako H, Nakamura T, et al. (2003) Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306: 756-766. (Pubitemid 37323827)
56. Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, et al. (2010) Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 84: 12048-12057.